Berberine Sensitizes Human Hepatoma Cells to Regorafenib via Modulating Expression of Circular RNAs

• Main Authors: Kunyuan Wang (Author), Ganxiang Yu (Author), Jiaen Lin (Author), Zhilei Wang (Author), Qianting Lu (Author), Chengxin Gu (Author), Tao Yang (Author), Shiming Liu (Author), Hui Yang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Regorafenib resistance is a key limiting factor in the treatment of advanced hepatocellular carcinoma (HCC). Increasing evidence has demonstrated that Berberine (BBR) can synergistically enhance the therapeutic effect of various chemotherapeutic agents. However, the contribution of BBR on regorafeni...